journal article·2009-12-09

Pathogen‐Mimicking MnO Nanoparticles for Selective Activation of the TLR9 Pathway and Imaging of Cancer Cells

Mohammed Ibrahim Shukoor, Filipe Natalio, Muhammad Nawaz Tahir, Matthias Wiens, Marco Tarantola, Helen Annal Therese, Matthias Barz, Stefan Weber, Maxim Terekhov, Heinz C. Schröder, Werner E. G. Müller, Andreas Janshoff, Patrick Theato, Rudolf Zentel, Laura Maria Schreiber, Wolfgang Tremel

Advanced Functional Materials· Volume 19· Issue 23
Publisher page

Abstract

Abstract Here, design of the first pathogen‐mimicking metal oxide nanoparticles with the ability to enter cancer cells and to selectively target and activate the TLR9 pathway, and with optical and MR imaging capabilities, is reported. The immobilization of ssDNA (CpG ODN 2006) on MnO nanoparticles is performed via the phosphoramidite route using a multifunctional polymer. The multifunctional polymer used for the nanoparticle surface modification not only affords a protective organic biocompatible shell but also provides an efficient and convenient means for loading immunostimulatory oligonucleotides. Since fluorescent molecules are amenable to photodetection, a chromophore (Rhodamine) is introduced into the polymer chain to trace the nanoparticles in Caki‐1 (human kidney cancer) cells. The ssDNA coupled nanoparticles are used to target Toll‐like receptors 9 (TLR9) receptors inside the cells and to activate the classical TLR cascade. The presence of TLR9 is demonstrated independently in the Caki‐1 cell line by western blotting and immunostaining techniques. The magnetic properties of the MnO core make functionalized MnO nanoparticles potential diagnostic agents for magnetic resonance imaging (MRI) thereby enabling multimodal detection by a combination of MR and optical imaging methods. The trimodal nanoparticles allow the imaging of cellular trafficking by different means and simultaneously are an effective drug carrier system.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neonatal Respiratory Health Research · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. 10.1038/ni152610.1038/ni1526 ↗
2. 10.1146/annurev.immunol.21.120601.14112610.1146/annurev.immunol.21.120601.141126 ↗
3. 10.1016/j.imbio.2004.03.00510.1016/j.imbio.2004.03.005 ↗
4. 10.1016/S0092-8674(00)81683-910.1016/S0092-8674(00)81683-9 ↗
5. 10.1038/ni111210.1038/ni1112 ↗
6. 10.1002/anie.20070473510.1002/anie.200704735 ↗
7. 10.1158/0008-5472.CAN-05-078410.1158/0008-5472.CAN-05-0784 ↗
8. 10.1158/0008-5472.CAN-05-394810.1158/0008-5472.CAN-05-3948 ↗
9. 10.1038/sj.onc.121090410.1038/sj.onc.1210904 ↗
10. Oncogene 2008 27
11. 10.4049/jimmunol.167.7.355510.4049/jimmunol.167.7.3555 ↗
12. 10.1073/pnas.16129349810.1073/pnas.161293498 ↗
13. Ojima I · 200110.1021/bk-2001-0796 ↗
14. 10.1016/S0169-409X(01)00184-310.1016/S0169-409X(01)00184-3 ↗
15. 10.1016/j.vaccine.2003.12.03210.1016/j.vaccine.2003.12.032 ↗
16. 10.1007/s11095-007-9410-510.1007/s11095-007-9410-5 ↗
17. 10.1097/00000658-195710000-0000710.1097/00000658-195710000-00007 ↗
18. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
19. Streffer C. · 1990
20. 10.1016/S0304-8853(99)00088-810.1016/S0304-8853(99)00088-8 ↗
21. 10.1016/j.jmmm.2005.01.06410.1016/j.jmmm.2005.01.064 ↗
22. 10.1038/nrc156610.1038/nrc1566 ↗
23. 10.1021/ja035931010.1021/ja0359310 ↗
24. 10.1038/nbt115910.1038/nbt1159 ↗
25. 10.1021/bc050290e10.1021/bc050290e ↗
26. 10.1161/01.RES.0000119321.18573.5A10.1161/01.RES.0000119321.18573.5A ↗
27. 10.1148/radiology.175.2.232647410.1148/radiology.175.2.2326474 ↗
28. 10.1002/aoc.75310.1002/aoc.753 ↗
29. 10.1021/ja036265610.1021/ja0362656 ↗
30. 10.1002/ange.20035240010.1002/ange.200352400 ↗
31. 10.1002/anie.20035240010.1002/anie.200352400 ↗
32. 10.1021/jp048229e10.1021/jp048229e ↗
33. 10.1039/B511920K10.1039/B511920K ↗
34. Goodenough J. B. · 1963
35. 10.1002/ange.20060477510.1002/ange.200604775 ↗
36. 10.1002/anie.20060477510.1002/anie.200604775 ↗
37. 10.1021/ja055592610.1021/ja0555926 ↗
38. 10.1021/jp056064j10.1021/jp056064j ↗
39. 10.1021/cm052492q10.1021/cm052492q ↗
40. 10.1021/cm062649u10.1021/cm062649u ↗
41. 10.1021/nl047996m10.1021/nl047996m ↗
42. 10.1006/taap.1998.857510.1006/taap.1998.8575 ↗
43. Goyer R. A. · Am. J. Clin. Nutr. · 1995 · 61 · 646s10.1093/ajcn/61.3.646S ↗
44. 10.1038/ni102810.1038/ni1028 ↗
45. 10.1002/smll.20060066410.1002/smll.200600664 ↗
46. 10.4049/jimmunol.173.2.117910.4049/jimmunol.173.2.1179 ↗
47. 10.1038/ni128010.1038/ni1280 ↗
48. 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U ↗
49. 10.1038/3504712310.1038/35047123 ↗
50. 10.1074/jbc.M60751120010.1074/jbc.M607511200 ↗
51. 10.1002/eji.20032423810.1002/eji.200324238 ↗
52. 10.1074/jbc.M31161820010.1074/jbc.M311618200 ↗
53. 10.1021/nn800721j10.1021/nn800721j ↗
54. 10.1016/j.eurpolymj.2005.01.02510.1016/j.eurpolymj.2005.01.025 ↗
55. 10.1021/mp060073a10.1021/mp060073a ↗
56. 10.1016/0003-2697(76)90527-310.1016/0003-2697(76)90527-3 ↗